Indications and uses
for help in control of superficial bleeding for temporary relief of pain and to help protect against skin infestion in minor cuts minor cuts minor scrapes minor burns
for help in control of superficial bleeding for temporary relief of pain and to help protect against skin infestion in minor cuts minor cuts minor scrapes minor burns
shake can well before using hold 6-8 inches from moist injured area spray until area is covered scan-like cover will gradually disappear as healing takes place or may be removed with soap and water for adult institutional use only not intended for use on children
Benzethonium Chloride 0.2% w/w
Lidocaine 4% w/w
Topical Antiseptic
Topical Anesthetic
for help in control of superficial bleeding
for temporary relief of pain and to help protect against skin infestion in minor cuts
minor cuts
minor scrapes
minor burns
For external use only
Flammable
keep away from flame
contents under pressure
do not puncture or incinerate
do not expose to temperatures above 120°(F)
in eyes or other mucous membranes
on large portions of the body
in case of deep or puncture wounds
on raw surfaces
on blistered areas
on animal bites
on serious burns
redness, swelling, or irritation occurs
infection occurs
condition persists or worsens
symptoms persist for more than 7 days
If swallowed, get medical help or contact a Poison Control Center right away.
shake can well before using
hold 6-8 inches from moist injured area
spray until area is covered
scan-like cover will gradually disappear as healing takes place or may be removed with soap and water
for adult institutional use only
not intended for use on children
Isobutane, Isopropyl Myristate, Karaya, N-Butane, Propane, Silica, Silicone, Sorbitan Monooleate, Talc, Tragacanth
| Class | Version | Type | Effective |
|---|---|---|---|
| LIDOCAINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 52982-106-03 | 2023-01-19 | C162847 | 48780-1 | 9855d018-dca0-cd31-e053-dbdaa90ab51a | YOUR LOGO HERE BLOOD CLOTTING SPRAY |
| 52982-106-03 | 2019-11-27 | C162847 | 48780-1 | 9855d018-dca0-cd31-e053-dbdaa90ab51a | YOUR LOGO HERE BLOOD CLOTTING SPRAY |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 52982-106-03 | Your Label Here Blood Clotting First Aid | 85 g in 1 BOTTLE, SPRAY | AEROSOL, SPRAY | 85 | 9 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 52982-106 | YOUR LABEL HERE BLOOD CLOTTING FIRST AID (BENZETHONIUM CHLORIDE AND LIDOCAINE) AEROSOL, SPRAY [DIXON INVESTMENTS, INC.] | 9 | Current NDC, Legacy NDC, 1 package rows | 20250130_b07ff274-6d4e-424a-89d2-683921947889.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| BENZETHONIUM CHLORIDE | ACTIVE INGREDIENT | PH41D05744 | 5 | |
| LIDOCAINE | ACTIVE INGREDIENT | 98PI200987 | 5 | |
| BENZETHONIUM | ACTIVE MOIETY | 1VU15B70BP | 5 | |
| LIDOCAINE | ACTIVE MOIETY | 98PI200987 | 5 | |
| 3-(TRIETHOXYSILYL)PROPYLAMINE | INACTIVE INGREDIENT | L8S6UBW552 | 5 | |
| BUTANE | INACTIVE INGREDIENT | 6LV4FOR43R | 5 | |
| ISOBUTANE | INACTIVE INGREDIENT | BXR49TP611 | 5 | |
| ISOPROPYL MYRISTATE | INACTIVE INGREDIENT | 0RE8K4LNJS | 5 | |
| KARAYA GUM | INACTIVE INGREDIENT | 73W9IQY50Q | 5 | |
| PROPANE | INACTIVE INGREDIENT | T75W9911L6 | 5 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 5 | |
| SORBITAN MONOOLEATE | INACTIVE INGREDIENT | 06XEA2VD56 | 5 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | 5 | |
| TRAGACANTH | INACTIVE INGREDIENT | 2944357O2O | 5 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 52982-106 | 52982-106-03 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ISOBUTANE | BXR49TP611 | IACT |
| ISOPROPYL MYRISTATE | 0RE8K4LNJS | IACT |
| KARAYA GUM | 73W9IQY50Q | IACT |
| BUTANE | 6LV4FOR43R | IACT |
| PROPANE | T75W9911L6 | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| 3-(TRIETHOXYSILYL)PROPYLAMINE | L8S6UBW552 | IACT |
| SORBITAN MONOOLEATE | 06XEA2VD56 | IACT |
| TALC | 7SEV7J4R1U | IACT |
| TRAGACANTH | 2944357O2O | IACT |
| LIDOCAINE | 98PI200987 | ACTIB |
| BENZETHONIUM CHLORIDE | PH41D05744 | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| BUTANE | BUTANE | 6LV4FOR43R | AEROSOL, FOAM / TOPICAL | 27 %w/w | ||
| BUTANE | BUTANE | 6LV4FOR43R | AEROSOL / TOPICAL | NA | ||
| BUTANE | BUTANE | 6LV4FOR43R | AEROSOL / TOPICAL | NA | ||
| BUTANE | BUTANE | 6LV4FOR43R | AEROSOL, FOAM / TOPICAL | 27 %w/w | ||
| ISOBUTANE | ISOBUTANE | BXR49TP611 | AEROSOL, SPRAY / TOPICAL | 4484 mg | ||
| ISOBUTANE | ISOBUTANE | BXR49TP611 | AEROSOL, SPRAY / TOPICAL | 4484 mg | ||
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | AEROSOL, SPRAY / TOPICAL | 6.89 %w/w | ||
| ISOPROPYL MYRISTATE | ISOPROPYL MYRISTATE | 0RE8K4LNJS | AEROSOL, SPRAY / TOPICAL | 6.89 %w/w | ||
| PROPANE | PROPANE | T75W9911L6 | AEROSOL, FOAM / TOPICAL | 55 %w/w | ||
| PROPANE | PROPANE | T75W9911L6 | AEROSOL, FOAM / TOPICAL | 55 %w/w | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / TOPICAL | 6 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / TOPICAL | 6 mg | ||
| SORBITAN MONOOLEATE | SORBITAN MONOOLEATE | 06XEA2VD56 | EMULSION / TOPICAL | 34050 mg | ||
| SORBITAN MONOOLEATE | SORBITAN MONOOLEATE | 06XEA2VD56 | EMULSION / TOPICAL | 34050 mg | ||
| SORBITAN MONOOLEATE | SORBITAN MONOOLEATE | 06XEA2VD56 | OINTMENT / TOPICAL | NA | ||
| SORBITAN MONOOLEATE | SORBITAN MONOOLEATE | 06XEA2VD56 | OINTMENT / TOPICAL | NA | ||
| SORBITAN MONOOLEATE | SORBITAN MONOOLEATE | 06XEA2VD56 | CREAM / TOPICAL | 11000 mg | ||
| SORBITAN MONOOLEATE | SORBITAN MONOOLEATE | 06XEA2VD56 | GEL / TOPICAL | 20 mg | ||
| SORBITAN MONOOLEATE | SORBITAN MONOOLEATE | 06XEA2VD56 | LOTION / TOPICAL | 7 mg | ||
| SORBITAN MONOOLEATE | SORBITAN MONOOLEATE | 06XEA2VD56 | SPRAY / TOPICAL | 8 mg | ||
| SORBITAN MONOOLEATE | SORBITAN MONOOLEATE | 06XEA2VD56 | CREAM / TOPICAL | 11000 mg | ||
| SORBITAN MONOOLEATE | SORBITAN MONOOLEATE | 06XEA2VD56 | SPRAY / TOPICAL | 8 mg | ||
| SORBITAN MONOOLEATE | SORBITAN MONOOLEATE | 06XEA2VD56 | GEL / TOPICAL | 20 mg | ||
| SORBITAN MONOOLEATE | SORBITAN MONOOLEATE | 06XEA2VD56 | LOTION / TOPICAL | 7 mg | ||
| TALC | TALC | 7SEV7J4R1U | POWDER / TOPICAL | 9235 mg | ||
| TALC | TALC | 7SEV7J4R1U | OINTMENT / TOPICAL | 74.6 %w/w | ||
| TALC | TALC | 7SEV7J4R1U | OINTMENT / TOPICAL | 74.6 %w/w | ||
| TALC | TALC | 7SEV7J4R1U | POWDER / TOPICAL | 9235 mg | ||
| TRAGACANTH | TRAGACANTH | 2944357O2O | JELLY / TOPICAL | NA | ||
| TRAGACANTH | TRAGACANTH | 2944357O2O | JELLY / TOPICAL | NA |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Your Label Here Blood Clotting First Aid | BENZETHONIUM CHLORIDE AND LIDOCAINE | Dixon Investments, Inc. | b07ff274-6d4e-424a-89d2-683921947889 | 2025-01-28 | Warnings | 52982-106-03 52982-106 52982010603 2cc58355-36ef-e429-e063-6394a90af68c b07ff274-6d4e-424a-89d2-683921947889 |